of insertion (women who were either pregnant or became pregnant very soon after implant insertion). 3 Liver enzyme-inducing drugs, including natural therapies like St John's Wort, are known to affect the efficacy of hormonal contraceptives including Implanon. 3 However, there are a small number of true method failures being reported. The present case demonstrates that these true method failures may result from rapid hormone metabolism.
During the research and development of new hormonal contraceptive methods a safety window is built in to take account of individual metabolic variation. Initial studies with Implanon demonstrated that less than 5% of women ovulated whilst using this contraceptive method. 4 Although Implanon's main contraceptive mode of action is to induce anovulation, it also exerts its contraceptive effects by altering the cervical mucus to reduce sperm penetration and altering the endometrium to prevent sperm survival and implantation of the blastocyst. 4 This patient had previously reported a method failure whilst taking the combined oral contraceptive pill. It can only be concluded that this unplanned pregnancy resulted from very low circulating levels of etonogestrel. Although Implanon is probably one of the most effective long-acting reversible methods of contraception (with failure rates quoted as <1 in 1000 women over a 3-year period) 5 this case demonstrates that there is a small group of women who may report repeated unplanned pregnancies whilst supposedly using effective hormonal contraceptive methods.
Where do we go from here? Organon Laboratories are supportive of investigating women with true method failures. If similar cases are identified then it would be helpful if the medical adviser at Organon Laboratories is contacted. Arrangements can be made to collect serum to be assayed for etonogestrel (prior to removing the implant) and if the implant is removed this too can be analysed. This small cohort of women may agree to further investigation in the future to aid contraceptive technology development.
At the present time the most satisfactory and effective contraceptive methods available to this group of women are progestogen-only injectables, copper intrauterine devices, the levonorgestrel intrauterine system or permanent fertility control methods.
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